Hostname: page-component-7c8c6479df-7qhmt Total loading time: 0 Render date: 2024-03-29T07:09:21.935Z Has data issue: false hasContentIssue false

Choice of neuroleptics in epilepsy

Published online by Cambridge University Press:  02 January 2018

James G. Longhurst
Affiliation:
Abraham Ribicoff Research Facilities, Department of Psychiatry and Connecticut Mental Health Center, Yale University, 34 Park Street, New Haven, Connecticut 06519
Erica L. Weiss
Affiliation:
Abraham Ribicoff Research Facilities, Department of Psychiatry and Connecticut Mental Health Center, Yale University, 34 Park Street, New Haven, Connecticut 06519
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1998 The Royal College of Psychiatrists

References

Honigfeld, G. (1996) Effects of the clozapine national registry system on the incidence of deaths related to agranulocytosis. Psychiatric Services, 47, 5256.Google Scholar
Naber, D., Holzbach, R., Perro, C., et al (1992) Clinical management of clozapine patients in relation to efficacy and side-effects. British Journal of Psychiatry, 160 (suppl 17), 5459.CrossRefGoogle Scholar
Pacia, S. V. & Devinsky, O. (1994) Clozapine-related seizures, Neurology, 44, 22472249.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.